Fluorescent Imaging in Thyroid Surgery to Preserve Parathyroid Function: A Systematic Review and Meta‐Analysis
Otolaryngology–Head and Neck Surgery · 2026
DOI: 10.1002/ohn.70055 ↗At a glance
Metaanalyse in Otolaryngology–Head and Neck Surgery, 2026. Written by Matthew H Cheung and 10 co-authors. Institution: Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA. Major MEDLINE topics: Hypocalcemia, Hypoparathyroidism, Optical Imaging, Parathyroid Glands. Cited 4 times so far (Crossref); 65 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Objective
Hypoparathyroidism and postoperative hypocalcemia are rare but dreaded complications of thyroid surgery, often requiring increased follow‐up and contributing to financial and quality‐of‐life burdens. This systematic review evaluates the effectiveness of intraoperative fluorescent imaging of parathyroid glands (PGs) in improving PG identification and reducing iatrogenic complications during thyroid surgery. Data Source Pubmed, Scopus, CINAHL. Review Methods A systematic search of PubMed, Scopus, CINAHL, and Cochrane databases was conducted per PRISMA guidelines. Studies using intraoperative fluorescent imaging for PG identification and reporting postoperative calcium and parathyroid hormone (PTH) levels were included. Data on patient demographics, surgical technique, imaging modality, PG identification rates, incidental parathyroidectomy, autotransplantation, and postoperative calcium/PTH outcomes were extracted. Meta‐analyses of proportions, odds ratios, and mean differences were performed using MedCalc and Cochrane Review Manager.
Results
Twenty‐eight studies (n = 3876) were included. Fluorescent imaging significantly improved PG identification rates (86.4% vs 70.6%, P < .0001) and reduced incidental parathyroidectomy (5.3% vs 9.5%, P = .0017). Short‐term hypoparathyroidism (16.7% vs 27.0%, P = .0004) and postoperative hypocalcemia rates on Day 1 (10.6% vs 18.1%, P = .0016) and in the short term (5.7% vs 11.5%, P = .0001) were significantly lower in the fluorescent imaging group. Odds of transient hypocalcemia were also reduced (OR 0.37, P < .00001).
Conclusion
Fluorescent imaging in thyroid surgery significantly improves PG identification rates and reduces the incidence of postoperative hypocalcemia and hypoparathyroidism. Integrating intraoperative fluorescent imaging into the intraoperative thyroid surgery paradigm may enhance patient outcomes by minimizing the frequency of PG‐associated complications.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
- College of Medicine, SUNY Upstate Medical University, Syracuse, New York, USA.
- Penn State College of Medicine, Hershey, Pennsylvania, USA.
ORCID profiles: Dauren Adilbay
Cite
APA
Cheung, M. H., Nguyen, M. T., Nguyen, S. A., Nassar, S. I., Murdaugh, J., Newman, J. G., Graboyes, E. M., Albergotti, W. G., Kejner, A., Bobian, M., & Adilbay, D. (2026). Fluorescent Imaging in Thyroid Surgery to Preserve Parathyroid Function: A Systematic Review and Meta‐Analysis. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.70055
Vancouver
Cheung MH, Nguyen MT, Nguyen SA, Nassar SI, Murdaugh J, Newman JG, et al. Fluorescent Imaging in Thyroid Surgery to Preserve Parathyroid Function: A Systematic Review and Meta‐Analysis. Otolaryngology–Head and Neck Surgery. 2026. doi:10.1002/ohn.70055
BibTeX
@article{Cheung2026,
author = {Cheung, Matthew H and Nguyen, Megan T and Nguyen, Shaun A and Nassar, Sami I and Murdaugh, Jesse and Newman, Jason G and Graboyes, Evan M and Albergotti, William G and Kejner, Alexandra and Bobian, Michael and Adilbay, Dauren},
title = {Fluorescent Imaging in Thyroid Surgery to Preserve Parathyroid Function: A Systematic Review and Meta‐Analysis},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2026},
doi = {10.1002/ohn.70055}
}
EUVIMED